Please login to read the full text of the article.
If you have no account yet, please register now.
Posted on
Previous Article
« Shared pathways for COVID-19 and diabetes? Next Article
HbA1c reduction with GLP-1RA leads to lower risk of CV events in cardiovascular outcome trials »
« Shared pathways for COVID-19 and diabetes? Next Article
HbA1c reduction with GLP-1RA leads to lower risk of CV events in cardiovascular outcome trials »
Related Articles
December 14, 2020
Timing of mealtime insulin can affect quality of life
December 2, 2021
Challenges in diagnosis and treatment of leprosy in Brazil
© 2021 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy